Docking studies on isoform-specific inhibition of phosphoinositide-3-kinases.
Reads0
Chats0
TLDR
The data suggest that conformational differences in Gln859, Ser854, Tyr836, and Ser774 may be used to design ligands that are active against both the wt and H1047R mutant isoforms, and structural and size differences in the activation and hydrophobic domains could be exploited to direct the design of isoform- and/or mutant-specific PI3K inhibitors.Abstract:
Phosphatidylinositol 3-kinase α (PI3Kα) is a promising target for anticancer drug design. Oncogenic mutation H1047R in the catalytic domain is observed in many tumors and may enhance PI3Kα kinase activity by affecting loop confirmations as well as membrane binding. We applied docking methods to 33 PI3K inhibitors against the wild type (wt) PI3Kα, the H1047R mutant of PI3Kα and the γ isoform of PI3K (PI3Kγ). We also investigated the effect of protein flexibility on ligand binding by docking the same set of ligands to conformations of the wt and mutant PI3Kα generated by molecular dynamics simulations. Our data suggests that conformational differences in Gln859, Ser854, Tyr836, and Ser774 between the PI3Kα wt and H1047R mutant may be used to design ligands that are active against both the wt and H1047R mutant isoforms. Gln859, Ser854 and Ser774 may play critical roles in ligand binding to the α isoform H1047R mutant while formation of H-bonds with Ser806 of PI3Kγ may enhance γ-isoform-specific inhibition. In addition to H-bond interactions, structural and size differences in the activation and hydrophobic domains of PI3Kα, PI3Kγ, and the PI3Kα H1047R mutant could be exploited to direct the design of isoform- and/or mutant-specific PI3K inhibitors. Our data provide a reasonable explanation for the activity and selectivity of small molecular PI3K inhibitors and are in good agreement with available experimental and computational data.read more
Citations
More filters
Journal ArticleDOI
A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types
Stephen M. F. Jamieson,Jack U. Flanagan,Sharada Kolekar,Christina M. Buchanan,Jackie D. Kendall,Woo-Jeong Lee,Gordon W. Rewcastle,William A. Denny,Ripudaman Singh,James M. J. Dickson,Bruce C. Baguley,Peter R. Shepherd +11 more
TL;DR: Results show that inhibition of p110α alone has the potential to block growth factor signalling and reduce growth in a subset of tumours.
Journal ArticleDOI
Bioinformatics and variability in drug response: a protein structural perspective.
TL;DR: This review summarizes structural characteristics of protein targets and common mechanisms of drug interactions, and describes the impact of coding mutations on protein structures and drug response.
Journal ArticleDOI
Rational Design of Phosphoinositide 3-Kinase α Inhibitors That Exhibit Selectivity over the Phosphoinositide 3-Kinase β Isoform
Timothy P. Heffron,Binqing Wei,Alan G. Olivero,Steven T. Staben,Vickie Tsui,Steven Do,Jennafer Dotson,Adrian Folkes,Paul Goldsmith,Richard Goldsmith,Janet L. Gunzner,John Lesnick,Cristina Lewis,Simon Mathieu,Jim Nonomiya,Stephen J. Shuttleworth,Daniel P. Sutherlin,Nan Chi Wan,Shumei Wang,Christian Wiesmann,Bing-Yan Zhu +20 more
TL;DR: It is proposed that select ligands achieve selectivity derived from a hydrogen bonding interaction with Arg770 ofPI3Kα that is not attained with the corresponding Lys777 of PI3Kβ that can be rationalized by the difference in electrostatic potential between the two isoforms in a given region.
Journal ArticleDOI
Computer-Aided Targeting of the PI3K/Akt/mTOR Pathway: Toxicity Reduction and Therapeutic Opportunities
Tan Li,Guanyu Wang +1 more
TL;DR: A variety of factors found to modulate the PI3K/Akt/mTOR pathway are reviewed, including gene mutations, certain metabolites, inflammatory factors, chemical toxicants, drugs found to rectify the pathway, as well as viruses that hijack the pathway for their own synthetic purposes.
Journal ArticleDOI
Structural Determinants of Isoform Selectivity in PI3K Inhibitors
TL;DR: An analysis of the available structure-selectivity-activity relationship data is presented to highlight key insights into how the various regions of the PI3K binding site influence isoform selectivity.
References
More filters
Journal ArticleDOI
Comparison of simple potential functions for simulating liquid water
TL;DR: In this article, the authors compared the Bernal Fowler (BF), SPC, ST2, TIPS2, TIP3P, and TIP4P potential functions for liquid water in the NPT ensemble at 25°C and 1 atm.
Journal ArticleDOI
Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems
TL;DR: An N⋅log(N) method for evaluating electrostatic energies and forces of large periodic systems is presented based on interpolation of the reciprocal space Ewald sums and evaluation of the resulting convolutions using fast Fourier transforms.
Journal ArticleDOI
Comparison of multiple Amber force fields and development of improved protein backbone parameters.
Viktor Hornak,Robert Abel,Asim Okur,Bentley Strockbine,Adrian E. Roitberg,Carlos Simmerling,Carlos Simmerling +6 more
TL;DR: An effort to improve the φ/ψ dihedral terms in the ff99 energy function achieves a better balance of secondary structure elements as judged by improved distribution of backbone dihedrals for glycine and alanine with respect to PDB survey data.
Journal ArticleDOI
High frequency of mutations of the PIK3CA gene in human cancers
Yardena Samuels,Zhenghe Wang,Alberto Bardelli,Natalie Silliman,Janine Ptak,Steve Szabo,Hai Yan,Adi F. Gazdar,Steven M. Powell,Gregory J. Riggins,James K V Willson,Sanford D. Markowitz,Kenneth W. Kinzler,Bert Vogelstein,Victor E. Velculescu +14 more
TL;DR: To determine if PI3Ks are genetically altered in tumorigenesis, they were sequenced in human for the first time and the results allowed us to assess the importance of phosphatidylinositol 3-kinases in neoplasia.
Journal ArticleDOI
Targeting the phosphoinositide 3-kinase pathway in cancer.
TL;DR: The potential of and challenges for the development of therapeutic agents that target this pathway in cancer are discussed and the potential and challenges in understanding of the PI3K pathway are highlighted.